Nihon Kohden (OTCMKTS:NHNKY) Sees Unusually-High Trading Volume – Here’s Why

Shares of Nihon Kohden Corporation (OTCMKTS:NHNKY) saw an uptick in trading volume on Tuesday . 62,391 shares changed hands during trading, an increase of 118% from the previous session’s volume of 28,598 shares.The stock last traded at $8.6550 and had previously closed at $8.54.

Analyst Ratings Changes

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy”.

Nihon Kohden Trading Up 1.6%

The stock has a market capitalization of $1.48 billion, a PE ratio of 14.70 and a beta of 0.40. The stock’s fifty day simple moving average is $9.13 and its 200-day simple moving average is $10.11.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The company had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. As a group, analysts anticipate that Nihon Kohden Corporation will post 0.6 earnings per share for the current fiscal year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.